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vascular bed after ischemia-reperfusion in
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Kaoru Takahashi-Sato1†, Masahiro Murakawa1, Junko Kimura2, Masa-aki Ito3 and Isao Matsuoka2,3*†Abstract
Background: Ectonucleotidase plays an important role in the regulation of cardiac function by controlling
extracellular levels of adenine nucleotides and adenosine. To determine the influence of ischemia-reperfusion injury
on ectonucleotidase activity in coronary vascular bed, we compared the metabolic profile of adenine nucleotides
during the coronary circulation in pre- and post-ischemic heart.
Methods: Langendorff-perfused rat hearts were used to assess the intracoronary metabolism of adenine
nucleotides. The effects of ischemia on the adenine nucleotide metabolism were examined after 30 min of
ischemia and 30 min of reperfusion. Adenine nucleotide metabolites were measured by high performance liquid
chromatography.
Results: ATP, ADP and AMP were rapidly metabolized to adenosine and inosine during the coronary circulation.
After ischemia, ectonucleotidase activity of the coronary vascular bed was significantly decreased. In addition, the
perfusate from the ischemic heart contained a considerable amount of enzymes degrading ATP, AMP and
adenosine. Immunoblot analysis revealed that the perfusate from the ischemic heart dominantly contained
ectonucleoside triphosphate diphosphohydrolase 1, and, to a lesser extent, ecto-5’-nucleotidase. The leakage of
nucleotide metabolizing enzymes from the coronary vascular bed by ischemia-reperfusion was more remarkable in
aged rats, in which post-ischemic cardiac dysfunction was more serious.
Conclusion: Ectonucleotidases were liberated from the coronary vascular bed by ischemia-reperfusion, resulting in
an overall decrease in ectonucleotidase activity in the post-ischemic coronary vascular bed. These results suggest
that decreased ectonucleotidase activity by ischemia may exacerbate subsequent reperfusion injury, and that levels
of circulating ectonucleotidase may reflect the severity of ischemic vascular injury.
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Adenine nucleotides and adenosine (Ado) are endogenous
modulators of cardiac function. Ado has cardiodepressive
effects, such as the negative chronotropic effect and the
inhibition of inotropic action of β adrenergic agonists, via
activation of the Ado A1 receptor [1]. In contrast to Ado,
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distribution, and reproduction in any mediumactions via the P2X ionotropic receptors [2]. However,
intravenous ATP has effects similar to those of Ado
through its rapid degradation to Ado [2-4]. Several lines of
evidence indicate that ATP is released from a wide variety
of cell types, such as endothelial cells, vascular smooth
muscle cells and platelets by physiological and mechanical
stimuli [5]. Therefore, regulated conversion of extracellu-
lar ATP to Ado plays an important role in purinergic regu-
lation of cardiac function.
Extracellular ATP catabolism is mediated by several
ectoenzymes, such as ectonucleoside triphosphate dipho-
sphohydrolases (ENTPD), ectonucleotide pyrophospha-
tases/phosphodiesterases and ecto-5’-nucleotidase (CD73)Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and CD73 [9] are thought to be involved in the conversion
of ATP to Ado. Recent studies suggested that ectonuc-
leotidase activity is altered under pathophysiological con-
ditions of the heart, such as myocardial ischemia and
chronic heart failure [10-13]. Activation of CD73 was
found in the preconditioned heart, which was induced by
brief periods of myocardial ischemia [11]. In contrast, oxi-
dative stress and inflammatory cytokines inactivate CD39
on the luminal surface of blood vessels, which in turn lead
to increased platelet aggregation [12]. These observations
suggest that individual enzymes involved in ATP catab-
olism may be affected differently under various patho-
physiological conditions, such as ischemia-reperfusion
injury.
In the present study, we examined ectonucleotidase
activity in the coronary vascular bed by administrating
adenine nucleotide substrates into the coronary circulation
of isolated rat hearts, and the effects of ischemia-reperfu-
sion on intracoronary ATP catabolism were investigated.Methods
Materials
ATP, ADP, AMP, Ado, α,β-methylene adenosine diphos-
phate (α,β-MeADP), hypoxanthine, inosine, levamisole,
ouabain, diethylpyrocarbonate were obtained from Sigma-
Aldrich (St. Louis, MO, USA). 1,N6-etheno adenosine-5’-
triphosphate (eATP), 1,N6-etheno adenosine-5’-diphos-
phate (eADP), 1,N6-etheno adenosine-5’-monophosphate
(eAMP) and 1,N6-etheno adenosine (eAdo) were obtained
from MP Biomedicals (Solon, OH, USA). ARL67156 was
from Tocris Bioscience (Ellisville, MO, USA). Anti-rat
CD39 polyclonal guinea pig antiserum and anti-rat CD73
monoclonal mouse antibody were obtained from Neu-
romics (Bloomington, MN, USA) and BD Biosciences
(San Jose, CA, USA), respectively. All other reagents were
of the highest purity available.Experimental animals
All animal experiments were performed in accordance
with the regulations of the Animal Research Committee
of Fukushima Medical University School of Medicine. In
this study, totally forty five male Wistar rats were used
for experiments; fifteen 8–10 weeks old rats for analysis
of the adenine nucleotide metabolism in the normal
coronary circulation, ten 8–10 weeks old rats (5 control
and 5 ischemia-reperfusion) for examining the effects of
ischemia reperfusion on the adenine nucleotide meta-
bolism in the coronary circulation, and ten aged rats
(24 months old, 5 control and 5 ischemia-reperfusion) and
ten young adult rats (8 weeks old, 5 control and 5
ischemia-reperfusion) for evaluating the effects of aging.Isolated heart perfusion
Rats were anesthetized by intra-peritoneal injections of
40 mg/kg sodium pentobarbital with 1000 U/kg heparin.
Under conditions of artificial ventilation, the heart was
rapidly excised and immediately mounted on a Langen-
dorff apparatus, and perfused with a physiological salt
(PS) solution at a constant flow rate of 5–8 mL/min
under which perfusion pressure was maintained 60–
70 mmHg, and was allowed to beat at an intrinsic heart
rate without pacing throughout the experiments. The PS
solution contained (in mmol/L): NaCl 130, NaHCO3
14.9, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, CaCl2 1.8 and
glucose 5.5. It was filtered through a nylon filter (0.4 μm,
Corning, NY, USA) to remove contaminants, and gassed
continuously with 95% O2 and 5% CO2, which resulted
in a pH of 7.35-7.4 and a pO2 > 80 kPa. The heart was
housed in a chamber that was maintained at 37°C. A
pressure transducer (TP-200 T, Nihon Kohden, Tokyo,
Japan) was connected to the perfusion line, and perfusion
pressure and heart rate (HR, beat /min) were monitored
through a carrier amplifier (AP601G, Nihon Kohden,
Tokyo, Japan). Data were continuously recorded and
analyzed using MacLab (AD-Instruments Pty Ltd., Castle
Hill, Australia). Normally, the heart rate ranged from 200
to 250 beats/min after 20 min of control perfusion.
Measurement of ectonucleotidase activity in the coronary
vascular bed
After stabilization of the beating heart for 20 min, PS
solution (0.3 ml) containing ATP, ADP, AMP and Ado at
100 μM was administered using an injection loop con-
nected to a perfusion line by three-way stopcocks at
5 min intervals. With this system, injection did not affect
the perfusion pressure. Test substrates were introduced
into the coronary circulation 20 sec after the injection,
and most of the substrates and their metabolites were
eluted from the heart within 1 min after the injection.
Samples of coronary effluent from the heart were col-
lected once for 20 sec immediately before, and five times
every 20 sec after injection of substrates. Aliquots of ef-
fluent (0.1 ml) were immediately mixed with an equal
volume of 10 mM ethylenediaminetetraacetic acid
(EDTA) and heated at 80°C for 5 min. This treatment
prevented the metabolites from further degradation by
endogenous nucleotidases released from the heart. The
first minute fraction after injection of the substrates
were pooled and adenine nucleotide metabolites were
analyzed using high performance liquid chromatography
(HPLC) with a UV detector as described below. In pre-
liminary experiments, we confirmed that the metabolic
profile of each substrate during coronary circulation was
not altered by repeated application at least 5 times. In
another set of experiments, eATP, eADP, eAMP and
eAdo at 10 μM were also used as substrates. These 1,
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leotidases [14], and their metabolites could be monitored
with a fluorescent detector, separated from endogenous
adenine nucleotides released during coronary circula-
tion. The etheno derivatives were administrated and
analyzed with the same protocol described for adenine
compound substrates.Effects of global ischemia on ectonucleotidase activity
After a 20 min stabilization of the heart, global ischemia
was induced by stopping the coronary perfusion by
changing to the surface perfusion using a three-way
stopcocks located above the aortic cannula. Therefore,
heart was not dry and its temperature was maintained at
37°C during the global ischemia. After 30 min of ische-
mia, the heart was reperfused with normal PS solution
for 30 min, and ectonucleotidase activity in the coronary
vascular bed was measured. In the experiments with the
post-ischemic heart, eATP and eAMP at 10 μM were
used as substrates for ectonucleotidase. Since eAdo was
not metabolized by or taken up into the coronary vas-
cular bed, Ado (100 μM) was used to determine the
change in adenosine deaminase (ADA) activity. At 5 min
intervals 0.3 ml of each substrate was injected. Col-
lection of effluents and analyses of metabolites were
performed as described above. The control heart was
perfused with normal PS solution for 80 min without
ischemia and then the ectonucleotidase activity was ex-
amined in the same way as that for the ischemic heart.Ischemia-induced release of adenine nucleotides
and ectonucleotidase
Ischemia was induced as described above. Immediately
after starting reperfusion, effluents were collected for
2 min at 20 sec intervals. Effluents before ischemia and
30 min after reperfusion were also collected to measure
the adenine nucleotide levels in the normal and post-
ischemia recovery states, respectively. Aliquots of 200 μl
of samples were mixed immediately with 200 μl of
10 mM EDTA and heated at 80°C for 5 min. The levels
of adenine nucleotides, Ado, inosine and hypoxanthine
were measured by HPLC. Ectonucleotidase activity in
the effluent was investigated by adding 0.2 ml of 10?μM
eATP, eAMP, or 100 μM Ado to 0.2 ml of the effluents.
After 10 min of incubation at room temperature, 0.4 ml
of 10 mM EDTA was added and the samples were
heated at 80°C for 5 min to stop the reaction. The me-
tabolites were analyzed by HPLC. The concentrations of
substrates remaining were corrected by subtracting the
concentrations of endogenous compounds present in the
samples, such as ATP and Ado, after parallel incubation
without added substrates.Measurement of LDH release from ischemic heart
LDH activity in the first minute coronary effluents from
ischemic heart was measured according to manufacturer
instructions, using Cytotoxicity Detection Kit (Roche
Applied Science, Indianapolis, IN).HPLC analysis of adenine nucleotide metabolites
The samples containing adenine nucleotide metabolites
were analyzed using a JASCO HPLC system equipped
with an analytical YMC-Pack ODS-A column (S-5, 4.6 X
100 mm, YMC Inc. Kyoto, Japan) equilibrated at 40°C
with 50 mM NaH2PO4 (pH 5.5 adjusted with H3PO4) at
a flow rate of 1 ml/min [15,16]. The HPLC system
consisted of a DG-980-50 degasser, LG-980-20 ternary
gradient unit, PO-980 pump, AS-950 autoinjector, CO-
966 column oven, MD-915 multi-wavelength detector
and FP-920 fluorescence detector (all from JASCO Cor-
poration, Tokyo, Japan). Samples were filtered through
0.2 mm nylon filters and kept at 4°C. The injection of
samples was followed by a 3 min flow of 50 mM NaH2
PO4 (pH 5.5) and a 5 min flow of a linear gradient of 0 -
20% (vol/ vol) methanol in 50 mM NaH2PO4 (pH 5.5).
After a 5 min flow of 20% methanol in 50 mM NaH2PO4
(pH 5.5), the eluent was changed to 50 mM NaH2PO4
(pH 5.5) and elution was continued for 7 min before the
next sample was injected. The range of wavelengths
scanned was 190–500 nm, and the absorption maxima
used for determining ATP, ADP, AMP and Ado were
260 nm and for inosine 247 nm and hypoxanthine
252 nm. The eATP metabolites were determined fluoro-
metrically with excitation and emission wavelengths at
270 and 410 nm, respectively. The peaks were identified
by comparison with the retention times of standards.Dot blot analysis
The existences of CD39 and CD73 in the effluents from
the ischemic heart were examined by dot blot analysis.
The effluents from pre- and post-ischemic heat were
applied to nitrocellulose membrane at the volume of
500 μl by using a vacuum blotting system. Cell lysates
(10 μg /100 μl) obtained from HEK293 cells transfected
with a pcDNA3.1 expression vector containing full
length cDNA of rat CD39 , rat CD73 or green fluores-
cent protein were used as positive and negative controls.
The membrane was then blocked with 3% BSA in Tris-
buffered saline containing 0.1% Tween-20 (TBST, pH 7.4),
followed by incubating anti-rat CD39 antiserum or anti-
rat CD73 monoclonal antibody diluted (1:500) with TBST
containing 1% BAS. The membranes were washed three
times with TBST and then incubated with horseradish
peroxidase conjugated second antibody. The signals were
detected by ECL-plus using LAS-3000 imaging system
(Fuji Photo Film Co. Tokyo, Japan).
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Results are presented as the means ± S.E.M. Statistical
analyses of the data were performed by the unpaired
Student’s t-test for two data comparison and one-way
analysis of variance (ANOVA) with the Dunnett two
tailed test for multiple data comparison. Pearson correl-
ation coefficients were calculated to examine the relation-
ship between the decrease in vascular ATPase activity and
the leakage of ATPase into coronary effluent after ische-
mia-reperfusion. P values less than 0.05 were considered
to be significant.
Results
Effects of adenine nucleotides and Ado on cardiac function
We examined the effects of the administration of aden-
ine nucleotides and Ado into the coronary circulation
on the cardiac function using the Langendorff perfusion
of isolated rat hearts. Addition of ATP, ADP, AMP or
Ado at 200 μM to the perfusate caused a sudden brady-
cardia with decreased perfusion pressure. A few seconds
after stopping, the heart started to beat again with a
sinus rhythm, and it took about 1 min to recover the
heart rate and perfusion pressure. All the nucleotides
and Ado had similar effects (data not shown). Therefore,
in the following experiments, we assessed how the nu-
cleotides were metabolized in the coronary circulation.
Metabolisms of adenine nucleotides and Ado in coronary
vascular bed
The coronary effluent from the Langendorff-perfused heart
did not contain any detectable adenine nucleotides or
their metabolites. When ATP and ADP were injected into0
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Figure 1 Metabolism of ATP (A), ADP (B), AMP (C) and adenosine (Ad
200 μM (0.3 ml) was added to the coronary perfusate after 20 min stabiliza
first one minute fraction after injection of the substrate were measured by
are shown as percent of total metabolites collected. All values are means ±the perfusate, they were almost completely metabolized to
AMP and Ado during a single pass (5–10 sec) through the
coronary circulation (Figure 1A, B). A considerable
amount of Ado converted from ATP or ADP was further
metabolized to inosine and hypoxanthine. When AMP
was used as a substrate, nearly 70% of it was converted to
Ado, which was also further metabolized to inosine and
hypoxanthine (Figure 1C). The relative amounts of metab-
olites, e.g. AMP (30%), Ado (40-45%), inosine (20%) and
hypoxanthine (5-10%) in the collected effluents, were
similar regardless of whether ATP, ADP or AMP was used
as a substrate, suggesting that enzyme activities hydrolyz-
ing ATP and ADP were extremely high in the coronary
vascular bed. In contrast, only about 30% of Ado injected
was converted to inosine (Figure 1D), suggesting that Ado
metabolism was relatively slow. Total recoveries of
injected ATP, ADP, AMP and Ado were 50–60%.
Similar metabolic profiles were obtained with etheno-
derivatives of adenine nucleotides except for eAdo, which
seemed to be the final metabolite (data not shown, see
Figure 2). Furthermore, the total recoveries of injected
etheno-substrates, including eAdo, were more than 90%,
suggesting that eAdo may not be uptake during coronary
circulation.
Effect of ischemia on ectonucleotidase activity in the
coronary vascular bed
When ischemia was induced by stopping the perfusion
inflow to the heart, spontaneous beating was arrested
within 10 min. After 30 min of ischemia, reperfusion
with normal PS solution resulted in a transient increase
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Figure 2 Effect of ischemia and reperfusion on metabolism of eATP (A), eAMP (B) and adenosine (C). After 20 min equilibration, the
hearts (n = 5) were subjected to a 30 min-ischemia, followed by reperfusion for 30 min. Each substrate at 10 μM (0.3 ml) was added to the
coronary perfusate and subsequent metabolites in the coronary effluents of the first one minute fraction after injection of the substrate were
measured by HPLC. Control metabolism was examined in heart after a time-matched control perfusion (80 min, n = 5). Open columns; metabolites
from the control hearts, dark columns; metabolites from ischemic heart. Data are shown as percent of total metabolites collected. All values are
means ± S.E.M (n = 5). *Significantly different from the control value at P < 0.05 by Student’s t-test.
Figure 3 Adenine nucleotide metabolites in the effluents
immediately after reperfusion. After 30 min-ischemia, hearts were
reperfused with a normal solution, and effluents were collected
every 20 sec for 120 sec. Effluents were also collected at
pre-ischemia. Endogenous adenine nucleotide metabolites released
from hearts into the effluents were measured by HPLC. Data are
means ±S.E.M (n = 10). Ado; adenosine, IN; inosine,
HX; hypoxanthine.
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http://www.biomedcentral.com/1471-2261/13/53increased pressure was decreased to the pre-ischemic
levels within 30 sec. Spontaneous heart beating was re-
stored within 30 seconds at the latest with a decreased
HR (60–75% of pre-ischemia), accompanied by serious
arrhythmia. The first 20 sec-fraction of reperfusate
(~1.5 ml) from ischemic heart contained Ado (8.0 ± 1.5
μM, n = 10) and inosine (40.4 ± 6.6 μM, n = 10), which
were absent in the perfusate from pre-ischemic heart
(Figure 3). The high level of inosine in the perfusate
was gradually decreased, whereas the Ado level was
maintained for 2 min following the start of reperfusion
(Figure 3).
We next examined the ectonucleotidase activities in
the coronary vascular bed of the post-ischemic heart
using eATP, eAMP as substrates (Figure 2). In the con-
trol heart, eATP (10 μM) was completely hydrolyzed to
eAMP, which was further partly metabolized to eAdo
(Figure 2A). The conversion of eAMP to eAdo was
greater compared to that of the natural substrate AMP
(Figure 1C and 2B). This may be due to a lack of re-
uptake of eAdo, resulting in eAdo accumulation. The
metabolism of eATP and eAMP in the ischemic heart
was clearly impaired (Figure 2A, B). Since eAdo is not a
substrate for ADA, Ado itself was used as substrate to
examine the change in Ado metabolism in the post-
ischemic heart. As shown in Figure 2C, the conversion
of Ado to inosine was also decreased in the ischemic
heart.Ectonucleotidase activity in the effluent from reperfusion
heart
During the measurements of endogenously released
metabolites in the post-ischemic reperfusates, we found
that the relative amounts of AMP, Ado and inosine in
the reperfusates were changed considerably unless the
samples were not heated at 80°C. This suggested that
the post-ischemic reperfusate contained enzyme(s) which
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Figure 4 Ectonucleotidase activity in the effluents of immediately after reperfusion. (A) Effluents collected as indicated in Figure 3 were
incubated with 100 μM ATP, AMP or adenosine (Ado) for 10 or 30 min, and the decrease in each substrate was measured by HPLC. All values are
means ± S.E.M (n = 5)Enzyme activities are shown as nmole substrate hydrolyzed by 1 ml effluent for 1 min. All values are means ± S.E.M (n = 5).
Lower panels show typical HPLC chromatograms of ATP (B) and AMP (C) hydrolyzed by the first fraction of post-ischemic reperfusate.






































Figure 5 Characteristics of ATPase and AMPase activity in the
effluents of immediately after reperfusion. A: The first and
second fractions (totally 40 sec after reperfusion) were pooled.
Aliquots of 100 μl sample were preincubated for 5 min with saline
(control), ouabain (Oua, 10 μM), levamisole (Lev, 500 μM),
diethylpyrocarbonate (DEPC, 500 μM), ARL67156 (ARL, 50 μM) or α,
β-MeADP (APCP, 10 μM, only in B), followed by adding ATP
(100 μM, A) or AMP (100 μM, B). The reactions were performed at
37°C for 5 min in A or 30 min in B, and the substrates remained
were measured by HPLC. Data shown are percentage of initial
substrate levels. Values are means ± S.E.M (n = 5). *Significantly
different from the control value at P < 0.05 by ANOVA, post-hoc
Dunnett analysis.
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the perfusates before ischemia did not contain any nucleo-
tidase activity. However, perfusates after ischemia con-
tained enzymes that hydrolyzed ATP, AMP and Ado. The
ATPase activity was most remarkable, and Ado degrad-
ation, which was due to ADA because inosine, detected as
a product, was also prominent, as compared with AMPase
activity (Figure 4A). These enzyme activities were highest
in the first 20-sec fraction of reperfusate, and then grad-
ually decreased. After 30 min reperfusion, no enzyme ac-
tivity was detected in the effluent. Figure 4B and C show
typical HPLC chromatograms, after hydrolyzing ATP and
AMP, respectively. ATP was hydrolyzed directly to AMP
without generating ADP, and Ado generated from AMP
was largely converted to inosine. ATP hydrolysis was
markedly inhibited by NTPDase inhibitors, ARL67156
(50 μM) and diethylpyrocarbonate (500 μM), but not by
ouabain (10 μM), a Na+-K+-ATPase inhibitor or levami-
sole (500 μM), an alkaline phosphatase inhibitor (Figure 5).
In addition, the CD73 inhibitor α,β-MeADP (10 μM)
abolished AMP hydrolysis (Figure 5). Actually, the pres-
ence of immunoreactive CD39 or CD73 was detected in
the first 20-sec fraction of reperfusate by dot blot analysis
(Figure 6), although CD73 level was very small.
Effects of aging on ectonucleotidase leakage induced
by ischemia reperfusion
It is well known that aging is a major risk factor for the
cardiovascular disorder induced by ischemia. Wetherefore examined whether ischemia-induced loss of
ecto-nucleotidase from the coronary vascular bed was
changed by aging. ATP hydrolysis activity in pre-ischemic
heart in aged rats (24 month old) was not different from
8-week old young adult rats (Figure 7A). However,
ischemia-induced decrease in ATP hydrolysis was more
significant in aged rats as compared to young rats (Fig-
ure 7B). Furthermore, the content of ATPase activity in









Figure 6 Detection of immunoreactive CD39 and CD73 in the
effluent of ischemia reperfusion. The effluent samples (300 μl)
from pre-ischemia (3) and ischemia-reperfusion hearts (4) were
applied to nitrocellulose membrane, and subjected to dot blot
analysis with anti-CD39 antibody (A) and anti-CD73 antibody (B). As
the negative and positive control, membrane extract (30 μg protein
in 300 μl) from HEK293 cells transfected with control pcDNA3vector
(1 in A and B) or CD39- (2 in A) and CD73-expressing plasmid (2 in
B) were used. Results shown are representative of three separate
sets of experiments.
Figure 7 Effects of aging on the changes in ATP hydrolysis
after ischemia-reperfusion in the coronary circulation . Control
perfusion and ischemia-reperfusion were performed as indicated in
Figure 2 in young adult and aged rats. A substrate of eATP (10 μM,
0.3 ml) was administrated into the coronary perfusate and
subsequent metabolites in the effluent were measured by HPLC.
Data are shown as percent of total metabolites collected from
control hearts (A) and ischemia-reperfusion hearts (B). Gray columns:
young adult rats , black columns: aged rats. All values are means ± S.
E.M (n = 5). *P < 0.05 , **P < 0.01 significantly different from the
control value by Student’s t-test.
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aged rats (Figure 8A). When data obtained from the
control and ischemic heart from both young and aged
rats were summarized on a scatter plot, there was a
strong negative correlation between the ATPase activity
leaked in the reperfusate and the decrease in ATPase
activity of coronary vascular bed (r = − 0.978, P <
0.0001, Figure 8B). With respect to functional responses,
spontaneous heart beating was restored within 10 seconds
of reperfusion after 30 min-ischemia in all young adult
8-week-old rats, whereas functional recovery was ob-
served in only 2 out of 5 aged rats. In addition, LDH
release from ischemic heart of aged rat (356 ± 18 mU/
ml, n = 4) was significantly higher (p < 0.05) than those
of young rat (215 + 32 mU/ml, n =5).
Discussion
Although it is well known that the vascular endothelial
cells possess highly active enzymes that hydrolyze extra-
cellular nucleotides [7-9], only limited information about
the overall metabolic profile of adenine nucleotides in
the coronary circulation is available in literature [3]. The
present study showed that the coronary vascular bed
possesses highly active ectoenzymes which catalyze ATP
hydrolysis. After a single pass of the coronary circula-
tion, ATP and ADP were converted almost totally to
AMP, and nearly 70% of the AMP was further metabo-
lized to Ado and inosine. The relative amounts of the
final metabolites from three different substrates, ATP,
ADP and AMP, were very similar; 30% AMP, 40-45%
Ado, 20% inosine and 5-10% hypoxanthine of the total
metabolites collected. This indicates that ATPase and
ADPase activities are much higher than AMPase activity,
and that the conversion of AMP to Ado is the rate-
limiting step in the formation of Ado from adenine nu-
cleotides in the rat heart coronary circulation. The levels
of inosine, which is produced from Ado by ADA, were
also similar when ATP, ADP, AMP or Ado were used as
substrates, showing that 30-40% of Ado was converted to
inosine. Thus, the relative potencies of ectonucleotidase
activities in the rat coronary vascular bed were ATPase,
ADPase > AMPase > ADA. Since coronary endothelium
expresses CD39 and CD73, it is suggested that ATP/
ADPase and AMPase activities are due to CD39 and
CD73, respectively. These results are consistent with
earlier work reported by Korchazhkina et al. [3].
The present results also demonstrated that ectonuc-
leotidase activity in the coronary vascular bed was signi-
ficantly decreased by ischemia-reperfusion. During the
acute phase of reperfusion, Ado and its metabolites, in-
osine and hypoxanthine, were released into the perfus-
ate. To distinguish between endogenous compounds
and metabolites of exogenous substrates, we used eATP
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Figure 8 Effects of aging on the leakage of ATPase from coronary vascular bed by ischemia-reperfusion. In the ischemia-reperfusion
experiments shown in Figure 7, the effluents immediately after reperfusion (20 second-fraction for 1 min) were collected and ATPase activity in
each sample was determined by incubating with ATP (100 μM) for 5 min (A). Data shown are levels of substrate ATP that remained in the
reaction mixture of young adult rats (gray column) and aged rats (black column). Values are means ± S.E.M (n = 5). *Significantly different from
the control value at *P < 0.05 by Student’s t-test. (B): A correlation analysis was performed on the results presented in Figure 7 and Figure 8A
from both young adult and aged rats (n = 20).
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http://www.biomedcentral.com/1471-2261/13/53pre- and post-ischemic coronary circulation. The eATP
and eAMP were metabolized in a manner similar to
ATP and AMP. However, eAdo was the final metabolite
from eATP or eAMP, because it did not seem to be the
substrate for ADA and Ado transporter. In the control
heart, eATP was completely converted to eAMP, which
metabolized further to eAdo during the coronary circu-
lation. With this system, we clearly showed that the hy-
drolysis of eATP and eAMP was significantly decreased
after 30 min ischemia. Although it has been shown that
oxidative stress and proinflammatory cytokines inhibit
CD39 activity in the endothelial cells [12] and the renal
vascular bed [17], little is known about the direct effect
of ischemia-reperfusion on CD39 activity in the coronary
vascular bed. Several studies have demonstrated that
up-regulation of CD39 and CD73 is involved in the car-
dioprotection by ischemia preconditioning. Since precon-
ditioning is induced by repetitive short period ischemia
(generally for 5 min each), it reflects an adaptive pheno-
menon rather than acute change after prolonged ischemia.
Indeed, significant up-regulation of CD39 and CD73
activities have been reported in post-ischemic brains
several days later, which seems to be also an adaptation
to post-ischemic inflammation [18,19]. The present results
show an acute change in ectonucleotidase activities after
ischemia.
Several mechanisms have been proposed for the alter-
ation of ectonucleotidase activity by pathophysiological
stimuli. With respect to the impairment of ectonucleo-
tidase activity, oxidative inactivation of CD39and CD73
was suggested from observations with NO generating
agents [20], inflammatory cytokine [21] and bacterial
lipopolysaccharide [22]. In the present study, we foundthat different ectonucleotidases were liberated from the
coronary vascular bed of the ischemic heart. Since car-
diac tissue contains a relatively high level of cytosolic 5’-
nucleotidase [23], as well as various ATP-dependent
enzymes, ATPase and AMPase activities in the post-
ischemic reperfusate may reflect the leakage of cytosolic
enzymes from necrotic cells. However, the following
lines of evidence suggest that the nucleotidase activities
detected in the post-ischemic reperfusate are originated
mainly from ectoenzymes. First, HPLC analysis clearly
showed that the ATP hydrolyzing enzymes in the
reperfusate had NTPDase activity, since ATP was dir-
ectly converted to AMP without generating ADP, being
consistent with the characteristic of CD39-meditated
ATP hydrolysis. If intracellular ATPase is involved in
ATP hydrolysis, the metabolites should include ADP.
Second, ATP hydrolysis was inhibited by the CD39 in-
hibitors ARL67156 and diethylpyrocarbonate, but not by
the intracellular ATPase inhibitors ouabain. Third, AMP
hydrolysis was inhibited by α,β-MeADP, which select-
ively inhibits CD73 but not cytosolic 5’-nucleotidase. Fi-
nally, dot bot analysis demonstrated that coronary
effluents from the ischemic heart contained immune re-
active CD39 and CD73. Therefore, we propose that the
liberations of these enzymes are from the luminal sur-
face of the coronary vascular bed.
It is well known that ischemic heart disease worsen
with age [24,25]. In this study, we showed that decrease
in ATP hydrolysis in coronary circulation by ischemia-
reperfusion were more remarkable in aged rats. We also
showed that ischemia-induced loss of ectonucleotidase
from the coronary vascular bed was accompanied by an
increase in ATPase release. There was a good negative
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coronary circulation and the degree of ATPase liberation
from the ischemic heart. These results indicate that de-
crease in ATP hydrolysis in ischemic heart is due to the
loss of ATPase activity from the luminal surface side of
the coronary vascular bed. Since these changes were re-
markable in aged rats, it is interesting to evaluate
whether circulating ATPase level could be a marker of
the ischemia-reperfusion injury in human.
The present study provides a novel mechanism that
explains the decrease in ectonucleotidase activity in is-
chemic heart coronary vascular bed. Although the post-
ischemic reperfusate contained different enzymes that
hydrolyze ATP, AMP and adenosine, the ATPase activity,
which may be due to CD39, was more remarkable com-
pared to AMPase and ADA. The selective decrease in
CD39 would increase the local concentrations of ATP
and ADP, which may cause increased platelet aggrega-
tion and exacerbation of ischemia and reperfusion injury
[12,13,17]. Therefore, it is important to clarify the me-
chanism underlying the selective CD39 decreased by
ischemia-reperfusion.
Limitation of this study is that we showed the decrease
in ectonucleotidase activity in coronary circulation after
global ischemia, whereas the myocardial infarction in
human heart is only subject to regional ischemia. Re-
cently, Bönner et al. [26] reported a significant decrease
in CD39 expression in coronary endothelial cells using
in vivo mouse myocardial infarction model. It is interest-
ing to examine whether similar mechanism shown in
this study is involved in the down-regulation of CD39
expression in post-ischemic coronary endothelial cells in
such in vivo model. Finally, we observed in preliminary
experiments that administration of adenine nucleotides
into the coronary circulation before induction of ische-
mia to evaluate the control ectonucleotidase activity
resulted in attenuating the ischemia-reperfusion-induced
loss of ectonucleotidase activity, so that we stopped to
compare the ectonucleotidase activity in pre- and post-
ischemic condition in the same heart, and designed
protocol as shown in Figure 2. This may reflect the
preconditioning effect of adenine nucleotides, especially
adenosine, on ischemic-reperfusion injury as previously
reported [11]. This may be important phenomenon that
should be examined.
Conclusion
In summary, this study demonstrates that the ischemia-
reperfusion elicits an overall decrease in ecto-nucleotid-
ase activities, including ATPDase, AMPase and ADA, in
the coronary vascular bed. In addition, this study shows
that these changes in ATP catabolism in coronary circu-
lation might be due to a significant liberation of ecto-
nucleotidases from ischemic coronary vascular bed. Thisidea was further supported in results obtained in aged
rats by showing that there was good correlation between
ischemia-reperfusion induced nucleotidase liberation
and decrease in ATP hydrolysis activity in ischemic cor-
onary circulation. These results may suggest that protec-
tion of ectonucleotidase liberation from the coronary
vascular bed is important for maintaining the post-ische-
mic cardiac function. Further study is needed to explore
the mechanism underlying ectonucleotidase liberation
caused by ischemia.
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